These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 1718594)

  • 41. NMR structure of a gemcitabine-substituted model Okazaki fragment.
    Konerding D; James TL; Trump E; Soto AM; Marky LA; Gmeiner WH
    Biochemistry; 2002 Jan; 41(3):839-46. PubMed ID: 11790105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study.
    Grunewald R; Kantarjian H; Du M; Faucher K; Tarassoff P; Plunkett W
    J Clin Oncol; 1992 Mar; 10(3):406-13. PubMed ID: 1740680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of thymidylate synthase by 2',2'-difluoro-2'-deoxycytidine (Gemcitabine) and its metabolite 2',2'-difluoro-2'-deoxyuridine.
    Honeywell RJ; Ruiz van Haperen VW; Veerman G; Smid K; Peters GJ
    Int J Biochem Cell Biol; 2015 Mar; 60():73-81. PubMed ID: 25562513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic interaction between cisplatin and gemcitabine in vitro.
    Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Peters GJ
    Clin Cancer Res; 1996 Mar; 2(3):521-30. PubMed ID: 9816199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines.
    van Moorsel CJ; Pinedo HM; Veerman G; Guechev A; Smid K; Loves WJ; Vermorken JB; Postmus PE; Peters GJ
    Biochem Pharmacol; 1999 Feb; 57(4):407-15. PubMed ID: 9933029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
    Santini V; Bernabei A; Gozzini A; Scappini B; Zoccolante A; D'Ippolito G; Figuccia M; Ferrini PR
    Haematologica; 1997; 82(1):11-5. PubMed ID: 9172997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of [3H]thymidine incorporation into DNA of rat regenerating liver by 2',2'-difluorodeoxycytidine coupled to lactosaminated poly-L-lysine.
    Di Stefano G; Busi C; Mattioli A; Derenzini M; Trerè D; Fiume L
    Biochem Pharmacol; 1999 Apr; 57(7):793-9. PubMed ID: 10075085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural basis for topoisomerase I inhibition by nucleoside analogs.
    Gmeiner WH; Yu S; Pon RT; Pourquier P; Pommier Y
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):653-8. PubMed ID: 14565246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
    Lech-Maranda E; Korycka A; Robak T
    Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and restriction enzyme analysis of oligodeoxyribonucleotides containing the anti-cancer drug 2',2'-difluoro-2'-deoxycytidine.
    Richardson FC; Richardson KK; Kroin JS; Hertel LW
    Nucleic Acids Res; 1992 Apr; 20(7):1763-8. PubMed ID: 1579470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N; Cournoyer D; Momparler RL
    Cancer Chemother Pharmacol; 1998; 42(5):373-8. PubMed ID: 9771951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacokinetic studies of dFdC (2',2'-difluorodeoxycytidine), ara-C and BH-AC (N4-behenoyl ara-C) in experimental animals].
    Okamoto M; Fujita H
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):439-44. PubMed ID: 1558392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU).
    Tiefenthaler M; Hohla F; Irschick E; Strasser-Wozak E; Bacher N; Mühlmann O; Wein W; Konwalinka G
    Immunobiology; 2003; 207(2):149-57. PubMed ID: 12675273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside.
    Bouffard DY; Momparler RL
    Leuk Res; 1995 Nov; 19(11):849-56. PubMed ID: 8551802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinase.
    Hodge LS; Taub ME; Tracy TS
    Drug Metab Dispos; 2011 Nov; 39(11):2013-6. PubMed ID: 21832002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine.
    Veltkamp SA; Pluim D; van Eijndhoven MA; Bolijn MJ; Ong FH; Govindarajan R; Unadkat JD; Beijnen JH; Schellens JH
    Mol Cancer Ther; 2008 Aug; 7(8):2415-25. PubMed ID: 18723487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell cycle effects of gemcitabine.
    Cappella P; Tomasoni D; Faretta M; Lupi M; Montalenti F; Viale F; Banzato F; D'Incalci M; Ubezio P
    Int J Cancer; 2001 Aug; 93(3):401-8. PubMed ID: 11433406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
    Vrana JA; Kramer LB; Saunders AM; Zhang XF; Dent P; Povirk LF; Grant S
    Biochem Pharmacol; 1999 Jul; 58(1):121-31. PubMed ID: 10403525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
    Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
    Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous quantification of 2',2'-difluorodeoxycytidine and 2',2'-difluorodeoxyuridine nucleosides and nucleotides in white blood cells using porous graphitic carbon chromatography coupled with tandem mass spectrometry.
    Jansen RS; Rosing H; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3040-50. PubMed ID: 19705384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.